Edition:
India

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

2.04USD
18 Oct 2019
Change (% chg)

$-0.14 (-6.42%)
Prev Close
$2.18
Open
$2.18
Day's High
$2.18
Day's Low
$1.99
Volume
226,919
Avg. Vol
367,500
52-wk High
$2.94
52-wk Low
$0.61

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Quarter Ending Mar-20 1 0.00 0.00 0.00 --
Year Ending Mar-19 3 0.00 0.00 0.00 --
Year Ending Mar-20 3 0.00 0.00 0.00 1.28
Year Ending Mar-21 4 4.97 16.00 0.00 3.96
Earnings (per share)
Quarter Ending Mar-19 2 -0.08 -0.05 -0.11 --
Quarter Ending Mar-20 2 -0.10 -0.08 -0.13 --
Year Ending Mar-19 2 -0.69 -0.54 -0.84 --
Year Ending Mar-20 4 -0.38 -0.17 -0.56 -0.40
Year Ending Mar-21 3 -0.23 -0.05 -0.45 -0.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.73 33.85
P/E High - Last 5 Yrs. -- 47.56 54.29
P/E Low - Last 5 Yrs. -- 27.30 28.22
Beta -- 1.00 0.99
Price to Sales (TTM) -- 6.00 7.90
Price to Book (MRQ) -- 3.84 4.38
Price to Tangible Book (MRQ) -- 4.14 5.07
Price to Cash Flow (TTM) -- 21.62 23.70
% Owned Institutions -- 0.79 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.83 1.67
Dividend Yield - 5 Year Avg -- 1.47 1.37
Dividend 5 Year Growth Rate -- 6.74 6.82
Payout Ratio(TTM) -- 50.64 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 13.42 14.65
Sales (TTM) vs TTM 1 Yr. Ago -- 6.45 8.45
Sales - 5 Yr. Growth Rate -- 8.32 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 18.49 19.40
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 5.66 7.15
Capital Spending - 5 Yr. Growth Rate -- 7.02 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.52
Current Ratio (MRQ) -- 3.55 3.52
LT Debt to Equity (MRQ) -- 11.64 12.61
Total Debt to Equity (MRQ) -- 16.17 17.64
Interest Coverage (TTM) -- 7.61 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.41 50.25
Gross Margin - 5 Yr. Avg. -- 50.53 51.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.64 16.42
Operating Margin (TTM) -- -2.19 -6.97
Operating Margin - 5 Yr. Avg. -- 13.94 11.87
Pre-Tax Margin (TTM) -- -2.50 -7.30
Pre-Tax Margin - 5 Yr. Avg. -- 18.73 15.72
Net Profit Margin (TTM) -- -6.21 -11.11
Net Profit Margin - 5 Yr. Avg. -- 14.06 11.11
Effective Tax Rate (TTM) -- 20.27 20.61
Effective Tax Rate - 5 Yr. Avg. -- 22.92 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 1,012,949,194 870,638,159
Net Income/Employee (TTM) -- 118,477,208 101,855,832
Receivable Turnover (TTM) -- 5.61 5.88
Inventory Turnover (TTM) -- 2.59 3.66
Asset Turnover (TTM) -- 0.88 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.57 10.25
Return on Assets - 5 Yr. Avg. -- 11.70 11.17
Return on Investment (TTM) -- 13.04 12.69
Return on Investment - 5 Yr. Avg. -- 14.80 14.15
Return on Equity (TTM) -- 14.12 17.13
Return on Equity - 5 Yr. Avg. -- 15.92 15.53
Note: Units in Millions of US Dollars

Performance for Acasti Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.